The Inequitable Conduct Defense — 1 Year After Therasense

In a case closely watched by patent litigators, the Federal Circuit Court of Appeals issued a decision last year that, on its face, seemed to impose tougher requirements for an accused...

Already a subscriber? Click here to view full article